# Elad Gil's latest AI bet is in healthcare; Abridge seeks USD 250 million at a USD 1 billion valuation

On 2024/10/10, The Information reported that Abridge, a US healthcare AI company, was raising USD 250 million at a USD 1 billion valuation, with approximately USD 50 million in annual revenue. It uses AI to transcribe doctor-patient conversations and automatically generate medical records, representing Elad Gil's latest investment in healthcare AI.



Canonical: https://uniquebase.ai/news/36571ff0-3bba-46e4-8ad5-18567c5e182d
Stable identifier: 36571ff0-3bba-46e4-8ad5-18567c5e182d
Snapshot captured: 2026-10-20T18:19:32.670Z
English updated: 2026-10-20T18:28:49.164Z

## Connected profiles

- [Abridge](/companies/abridge)
- [Bessemer Venture Partners](/institutions/bessemer-venture-partners)
- [California Health Care Foundation](/institutions/california-health-care-foundation)
- [CapitalG](/institutions/capitalg)
- [Elad Gil](/institutions/elad-gil)
- [IVP](/institutions/ivp)
- [NVIDIA](/institutions/nvidia)

## Sources

- https://www.theinformation.com/articles/elad-gils-latest-ai-bet-is-in-health